Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Meeker David P sold 50,000 Rhythm Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 14, 2026 · Filed Sep 14, 2026
On Sep 14, 2026, Meeker David P (Director, President and CEO) sold 50,000 Rhythm Pharmaceuticals, Inc. shares at an average US$102.67 for US$5.13M under a trading plan, leaving 239,258 shares. Filed Sep 14, 2026 (Form 4).
- Sold
- 50,000 shares
- Price
- US$102.67 average (US$101.75 to US$105.19)
- Value
- US$5.13M
- Holding after
- 239,258 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | Option exercise | 50,000 | US$6.05 | 289,258 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 6,439 | US$101.75 | 282,819 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 30,746 | US$102.35 | 252,073 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 8,698 | US$103.43 | 243,375 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 1,817 | US$104.55 | 241,558 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 2,300 | US$105.19 | 239,258 | Direct |